PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 55: Articles 27001-27500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Family planning policies.
  2. The family planning program among the Indian population of Guatemala.
  3. Family planning program as an integrated part of general health programs for mother and child.
  4. Family planning program Bangladesh.
  5. Family planning program effectiveness: report of a workshop.
  6. Family planning program effectiveness: report of a workshop.
  7. Family planning program in Mojokerto: an integrated approach.
  8. The family planning program in Taiwan: did it make any difference?
  9. Family planning program initiated in Zambia, Africa; transportation, communication cause problems.
  10. Family planning program management: a selected annotated bibliography.
  11. Family planning program, Taiwan area, Republic of China, July 1977-June 1979.
  12. Family planning program: rules and procedures. [Programa de planificacion familiar: normas y procedimientos.]
  13. Family planning programme and abortion laws in Zambia.
  14. Family planning programme at P.T. Imbritex: an example of family planning within occupational health activities.
  15. Family planning programs or development: how persuasive is the new wisdom?
  16. Family planning programs: an evaluation of experience.
  17. Family planning project in an enterprise: the case of Kaum Ho Tire Industrial Co.
  18. Family planning services by traditional birth attendants.
  19. The family planning success story.
  20. A family planning survey of Arbaji Village in Gezira Area, Sudan.
  21. Family planning visits to private physicians.
  22. Family planning [Editorial]
  23. Family planning, contraception and abortion in author's transl) [Planification des naissances, contraception et avortement au Quebec.]
  24. Family planning, nutrition, and parasite control programme, Davao City, Philippines.
  25. Family planning.
  26. Family planning. [Familienplanung.]
  27. Family planning. [Familienplanung.]
  28. Family planning. [Planejamento familiar.]
  29. Family planning. [Planificacion familiar.]
  30. Family planning: a basic and essential activity in maternal-child health programs.
  31. Family planning: a component of Cuba's public health program.
  32. Family planning: Muslim style.
  33. Family Size, contraceptive practice, and fertility intentions in England and Wales, 1967-1975.
  34. The fear barrier to teenage birth control.
  35. A feasibility study for increasing self-supporting family planning acceptors in the Korean urban population: final report (Author's transl)
  36. A feasibility study on the new target system for the Korean family planning program (author's transl)
  37. Female contraception and sterilization.
  38. Female contraception: (1) methods, indications, complications. [La contraception feminine: (1) methodes, indications, complications.]
  39. Fertility and contraception. [Fecondite et contraception.]
  40. Fertility and contraceptive behavior: Danfa Project.
  41. Fertility and family planning in a rural community in Matara district.
  42. Fertility and family planning in a rural community in Puttalam district.
  43. Fertility and family planning in Hanover Park: data for 1969, 1974, 1976. [Fertiliteit en gesinsbeplanning in Hanover Park: gegewens vir 1969, 1974 en 1976.]
  44. Fertility and family planning in rural Northern Thailand.
  45. Fertility and family planning trends in Java and Bali.
  46. Fertility and the need for family planning services in three Latin American populations.
  47. Fertility estimation: a comparison of results of Contraceptive Prevalence Surveys in Paraguay, Sao Paulo State, Brazil, and El Salvador.
  48. Fertility measurement: 1978 Contraceptive Prevalence Survey, El Salvador.
  49. Fertility policies and the National Family Planning and Population Program.
  50. Fertility policies and the National Family Planning and Population Programme.
  51. Fertility trends and contraception practices of hospital personnel.
  52. Fertility trends and planned parenthood: (summary report on a subregional working group meeting)
  53. Fertility trends in Ceylon 1953-1968 and the National Family Planning programme.
  54. Fertility, mortality, migration and family planning in Haiti.
  55. Fertility, pregnancy and contraception.
  56. Fibrinolysis, renin activity, and prorenin in normal women: effects of exercise and oral contraceptive medication.
  57. Fibroadenoma in oral contraceptive users: a histopathologic evaluation of epithelial atypia.
  58. Field tests with an oral contraceptive: results with an estrogen-reduced contraceptive for the symptom of tight breast. [Feldpruefung mit einem oralen Kontrazeptivum: Ergebnisse mit einem oestrogenreduzierten Kontrazeptivum beim Symptom Brustspannen.]
  59. Fieldworker study: a study of the fieldworkers in the Federation of Family Planning Associations, Malaysia 1978.
  60. Filipino values on family life as reflected in Philippine print advertisement: implications for family planning communication.
  61. Final report of an alternative delivery system providing MCH and family planning services through Tong/Ban chiefs in order to maximize family planning acceptance in an urban low income area (author's transl)
  62. The first three-stage preparation for hormonal contraception: clinical results. [Erstes Dreistufenpraeparat zur hormonalen Konseptionsverhuetung: klinische Ergebnisse.]
  63. First year clinical experience with six levonorgestrel rods as subdermal contraception.
  64. Follow-up observations of the so-called normophasic method of hormonal contraception. [Eine Follow-up-Betrachtung zur sogenannten normophasischen Methode der hormonalen Kontrazeption.]
  65. A follow-up survey of sterilization acceptors in the modified contraceptive distribution project.
  66. Four cases of benign hepatic-tumors associated with oral contraception. [A propos de quatre observations d'adenomes hepatiques apparus chez des femmes soumises a une association oestro-progestative.]
  67. French legacies (and their effects on attitudes toward family planning)
  68. Frequency and duration of taking oral contraceptives by tumor patients. [Haeufigkeit der Einnahme oraler Kontrazeptiva bei Tumorpatienten.]
  69. FTC's OTC vaginal contraceptive and investigation.
  70. Functional review of drugstores in contraceptive distribution: Cheju area (author's transl)
  71. Further results about pregnancy and childbirth after use of oral contraceptives (author's transl) [Weitere Ergebnisse ueber Schwangerschaft und Geburt nach Anwendung von Ovulationshemmern.]
  72. Future developments in intrauterine contraception.
  73. Future prospects in female contraception.
  74. Future prospects in male contraception.
  75. Gall bladder troubles and oral contraceptives (author's transl) [Les troubles vesiculaires au cours de la contraception orale.]
  76. Gallup Poll says 80% of American adults who approve of contraception approve of voluntary sterilization.
  77. Gambia maternal and child health/family planning.
  78. Gandhigram Institute of Rural Health and Family Planning, India.
  79. Gastroenterological side effects of oral hormonal contraceptives. [Gastroenterologische Nebenwirkungen oraler hormoneller Antikonzeptiva.]
  80. The general practitioner and family planning.
  81. Genital mycoplasma in intrauterine contraceptive device users.
  82. Ghana: half the fertility reduction in a rural area is due to acceptance by men of family planning.
  83. Gossypol - proposed contraceptive for men passes the Ames test.
  84. Gossypol under test as male oral contraceptive (in the People's Republic of China)
  85. Gossypol, a new contraceptive agent for men. [Gossypol, novy anticoncepcni prostredek pro muze.]
  86. Gossypol, a new contraceptive for men.
  87. Gossypol: a male contraceptive.
  88. Government strategies for expanding surgical family planning services (author's transl)
  89. Gregory Pincus and steroidal contraception: a new departure in the history of mankind.
  90. Guatemala Contraceptive Prevalence Survey: 1978. [Tables]
  91. Guatemala: family planning training for traditional birth attendants. [Project description]
  92. A guide to contraceptives] [tables. [Guia de anticonceptivos.]
  93. Guide to population/family planning information sources.
  94. A guide to prescribing oral contraceptives.
  95. Guidelines to birth control counselling of the physically handicapped.
  96. Guizhou officials punished for ignoring birth control regulations.
  97. Haemoglobin levels in contraceptive users.
  98. Health (Family Planning) Bill 1978. (Editorial)
  99. Health (Family Planning) Bill, 1978. [Letter]
  100. Health education evaluation and beliefs and practices in rural Tamil Nadu. 2. Family planning and antenatal care.
  101. Heavy legs and oral contraceptives. [Jambes lourdes et contraceptifs oraux.]
  102. The hemodynamic effects of oral contraceptives (author's transl) [Les effets hemodynamiques des contraceptifs oraux.]
  103. Hepatic lesions by oral contraceptives. [Lesioni epatiche da contracettivi orali.]
  104. Hepatic neoplasms associated with contraceptive and anabolic steroids.
  105. Hepatic sinusoidal dilatation related to oral contraceptives: a study of two patients showing ultrastructural changes.
  106. Hepatic tumor and prolonged oral contraception (Author's transl) [Levertumor og langvarigt p-pilleforbrug.]
  107. Hepatic tumors and oral contraceptives. [Tumeurs hepatiques et anticonceptionnels oraux.]
  108. Hepatocellular carcinoma after oral contraception. [Maligner Lebertumor nach oraler Kontrazeption.]
  109. Hepatocellular carcinoma in a patient on oral contraception who had been exposed to hepatitis B virus.
  110. High density lipoprotein cholesterol levels in peripheral vascular disease and in women on oral contraception.
  111. High infant mortality may signal readiness to initiate vigorous family planning effort.
  112. The histopathology of liver tumors in oral contraceptive users observed during a national survey by the American College of Surgeons Commission on Cancer.
  113. Historical criteria for the evaluation of the risk in hormonal contraception. [Criteri anamnesici per una valutazione del rischio nella contraccezione ormonale.]
  114. A history of the IPPF in the world family planning movement.
  115. History, Family Planning Association of Kenya.
  116. Hong Kong: legal aspects of family planning.
  117. Hong Kong: The Family Planning Association continues its pioneering role.
  118. Hormonal contraception (author's transl) [Hormonale Kontrazeption.]
  119. Hormonal contraception and metabolism of the lipids. [Contraception hormonale et metabolisme des lipides.]
  120. Hormonal contraception for the man. [Metodos hormonales para el varon.]
  121. Hormonal contraception today. [Hormonell antikonception av i dag.]
  122. Hormonal contraception with skin implant and vaginal rings. [Anticonception hornomal con implantes subdermicas y anillos vaginales.]
  123. Hormonal contraceptives and carbohydrate metabolism. [Hormonale Kontrazeptiva und Kohlenhydratstoffwechsel.]
  124. Hormonal tissue concentration and oral contraceptives: the endometrium. [Concentracion hormonal tissular y los anticonceptivos orales: el endometrio.]
  125. House to house sampling of contraceptive products Ciudad Netzahualcoyotl-Mexico D.G. - October, November and December - 1979.
  126. Household distribution of contraceptives in Bir Ali ben Khalifa, Tunisia.
  127. Household distribution of contraceptives in rural Egypt.
  128. How to involve men in family planning: a workbook.
  129. Human cervical mucus v. oral contraceptives and mucus rheologic properties.
  130. Human chorionic gonadotropin beta-subunit-like immunoreactive material in the plasma of women wearing an intrauterine progesterone contraceptive system.
  131. Human hexosaminidase isozymes. 4. Effects of oral contraceptive steroids on serum hexosaminidase activity.
  132. Human platelet aggregation curve and oral contraception.
  133. Humanistic family planning.
  134. Hunan announces planned parenthood regulations.
  135. Hysteroscopy an intrauterine contraception.
  136. I'm just too tired with the work and these babies. Nutrition, health, and family planning.
  137. Icterus induced by oral contraceptives. [Les icteres des contraceptifs oraux.]
  138. Identical hormonal contraceptives inducing different side-effects in a patient.
  139. The ideology and politics of birth control in inter-war England.
  140. IE & C for family planning in Morocco: program development in the Moroccan Family Planning Association.
  141. Illustrative analysis: contraceptive sterilization and births averted in Panama.
  142. Illustrative analysis: socio-economic determinants of contraceptive use in Thailand.
  143. Immediate postabortion intrauterine contraception in nulliparous adolescents.
  144. Immediate postpartum insertion of copper-wired intrauterine contraceptive device, the MLCu250.
  145. Immune reactivity of women on hormonal contraceptives: dinitrochlorobenzene sensitization test and skin reactivity to irritants.
  146. Immune studies in oral contraceptive users.
  147. The impact and effectiveness study of the Community Based Family Planning Services Program in the Zahrani Area (south of Lebanon)
  148. Impact of family planning in Orissa.
  149. The impact of family planning in three urban non-white communities.
  150. Impact of family planning nurse practitioners.
  151. The impact of family planning upon fertility within the departments of Colombia.
  152. Impact of M.T.P. on family planning.
  153. The impact of mother daughter communication on daughter's deficiency. (Author's) sexual knowledge, behavior and contraceptive use.
  154. Implementation of researches for population and family planning program.
  155. Implementing a natural family planning model.
  156. The implications of surgical contraception for family health.
  157. Importance of HDL-cholesterol as a negative risk factor and the relationship between HDL and oral contraceptives. [Het belang van HDL-cholesterol als negatieve risicofactor en het verband tussen HDL en orale contraceptiva.]
  158. The importance of vaginal contraception.
  159. Incentives and disincentives in family planning.
  160. The incorporation of natural family planning into the health sector.
  161. Increased platelet aggregation and decreased high-density lipoprotein cholesterol in women on oral contraceptives.
  162. Increased risk of thrombosis due to oral contraceptives: a further report.
  163. India restores family planning.
  164. India's family planning program recovering slowly from setbacks: voluntarism emphasized.
  165. Indications, methods and limits of estrogen therapy (outside contraception) [Indications, modalites et limites de l'estrogenotherapie (en dehors de la contraception)]
  166. Indomethacin in the Therapy of Hemorrhage Complicating Intrauterine Contraception. [Indometacin v lecbe kvvaceni komplikujiciho nitrodelozni antikoncepci.]
  167. Induction of aryl hydrocarbon hydroxylase by lymphocytes from women taking oral contraceptives.
  168. Induction of hepatic drug metabolizing enzymes and pregnancy while taking oral contraceptives. (Editorial)
  169. Infant mortality, birth order and contraception in India.
  170. Infertility and family planning.

     

  171. Infertility and family planning. [Infertilidade E Planejamento Familiar.]
  172. The influence of acetylsalicylic acid and paracetamol on menstrual blood loss in women with and without an intrauterine contraceptive device.
  173. The influence of government policies on maternal child health and family planning programmes in Singapore.
  174. Influence of mineral intake and use of oral contraceptives before pregnancy on the mineral content of human colostrum and of more mature milk.
  175. Influence of oral contraceptives on ascorbic acid and triglyceride status.
  176. Influence of oral contraceptives on changes of the carbohydrate metabolism. [Utjecaj oralnih kontraceptiva na promjene metabolizma ugljikohidrata.]
  177. Influence of oral contraceptives on psychic status and sexuality.
  178. Influences on family planning acceptance: an analysis of background and program factors in Malaysia.
  179. Information on health and family planning context in Mojokerto.
  180. Injectable contraception with norethisterone oenanthate: a review of clinical data and first experiences with a modified application scheme.
  181. Injectable contraceptives: how safe are they?
  182. Injectable contraceptives: usage and problems. [Anticonceptivos inyectables: uso y problemas.]
  183. Injectable non-occlusive chemical contraception in the male-I.
  184. Innovations in health care delivery in rural areas based on experiences from the Calabar Rural Maternal Child Health/Family Planning Programme, Nigeria.
  185. Innovative family planning projects in Bangladesh.
  186. Innovative family planning strategies developed in the Republic of South Africa.
  187. Institutional capabilities of seven Panamanian organizations to conduct family planning/sex education activities.
  188. Insurance, birth control, abortion and sterilization (interview) [L'assurance, la regulation des naissances, l'avortement et la sterilisation.]
  189. Integrated family planning and parasite control project in Nepal.
  190. Integrated family planning and parasite control project, Malaysia.
  191. The integrated family planning, nutrition and parasite control project.
  192. Integrating family planning and health at the village level: training methods.
  193. Integrating natural family planning with a mother and child health programme at St. Joseph's Hospital, Choondal, Kerala.
  194. Integrating parasite control and family planning.
  195. Integration of family planning activities in basic health services with particular reference to maternal and child health.
  196. Integration of women in family planning.
  197. Intelligence, family planning and family size. [Intelligentie, gezinsplanning en gezinsvorming.]
  198. Interaction between anticoagulants and contraceptives: an unsuspected finding.
  199. The interaction between legalization of abortion and contraception in Denmark (author's transl) [Interaction entre la legalisation de l'avortement et la contraception au Danemark.]
  200. The interaction between legalization of abortion and contraception in Denmark.
  201. Interaction between rifampicin, steroids and oral contraceptives. [Letter]
  202. Interactions between oral contraceptives and other drugs.
  203. Interference of contraception in the sexual life of the couple. [Interferenze della contraccezione sulla vita sessuale della coppia.]
  204. Interfering unconscious meanings in adolescent resistance to oral contraception.
  205. International health information exchange project capsule: Danfa comprehensive rural health and family planning project.
  206. International maternity care monitoring: contraceptive behavior/service in Asia.
  207. The international status of voluntary surgical contraception and its implications for national health programs.
  208. Intestinal infarction caused by mesenteric venous thrombosis during contraceptive treatment. [Infarto intestinale da trombosi venosa mesenterica in corso di trattamento contraccettivo.]
  209. Intestinal parasite infection as a deterrent against acceptance of family planning in rural Bangladesh.
  210. Intra-village communication networks and family planning acceptance in rural Korea.
  211. Intracisternal hyalin and giant mitochondria in hepatocytes and oral contraceptives (Author's transl) [Intrazisternales Hyalin und Riesenmitochondrien in Hepatozyten und oral Kontrazeptiva.]
  212. Intrahepatic cholestasis and thromboembolism disease due to oral contraceptives. [Colestasis intrahepatica y enfermedad tromboembolica por anticonceptivos orales.]
  213. Intranasal gonadotropin-releasing hormone agonist as a contraceptive agent.
  214. Intrauterine contraception with Copper T and Gravigard: a follow-up study from general practice. [Intrauterin prevensjon med Copper-T og Gravigard: en etterundersokelse fra almenpraksis.]
  215. Intrauterine contraception.
  216. The intrauterine contraceptive device and acute salpingitis: a multifactor analysis.
  217. Intrauterine contraceptive devices: uniform labelling regulation.
  218. Intrauterine progesterone contraceptive system as an alternative in cases where conventional IUDs are unsuitable.
  219. Intravaginal contraception with the synthetic progestin, R2010.
  220. Intravaginal contraception: United Nations Fund for Population Activites.
  221. Intravaginal contraception: United Nations Fund for Population Activities.
  222. Intravaginal female contraceptives. [Anticonceptivos femeninos de barrera.]
  223. The introduction of a family planning program to Akhas in Thailand. (Doctoral dissertation, University of Oregon, March 1978)
  224. Introduction to contraception.
  225. Introduction to contraception.
  226. Inventory series on IEC materials on population and family planning 1974-1978.
  227. Involvement of the private physician in the family planning programs: pilot study. [Integracion del medico privado a los programas de planificacion familiar: estudio piloto.]
  228. Involving men in family planning: a model of appropriate technology.
  229. Ireland okays contraceptive sales, but bans free distribution.
  230. Irish Bill on contraception.
  231. Irreversible methods: their place in the Thai family planning programme.
  232. Irritable bladder induced by copper-containing intrauterine contraceptive devices (Author's transl) [Irritable blaere forarsaget af antikonception med intrauterin kobberspiral.]
  233. Is the public rural health service an effective context for delivering family planning services?
  234. IUD and family planning in Brazil.
  235. IUD and family planning in Indonesia.
  236. IUD and family planning in Latin America.
  237. IUD and family planning in Nigeria.
  238. IUD and family planning in South East Asia.
  239. IUD and family planning in Thailand.
  240. The IUD and family planning in the United States.
  241. IUD and family planning in U.S.A.
  242. IUD compared with oral contraception in nulliparae.
  243. IUD component in family planning programs in Sri Lanka and Pakistan.
  244. IUDs and family planning in Middle East.
  245. IUDs and oral contraceptives: a follow-up study of 504 women (author's transl) [IUP och p-piller: Uppfoeljning av hur dessametoder funger at foer 504 kvinnor.]
  246. Jaundice by interaction of troleandomycin and contraceptive pills: 3 observations (letter) [Ictere apres association estroprogestatif-troleandomycine: trois observations.]
  247. Knowledge and practice in family planning of Thai women.
  248. Knowledge of contraception and women's contraceptive status in the Socialist Republic of Serbia. [Obavestenost o kontracepciji i kontraceptivni status zena u SR Srbija.]
  249. Knowledge, attitude and performance of rural communities toward the obstetric and family planning services. [Pengetahuan, sikap, perilaku masyarakat pedesaan terhadap pelayanan obstetri dan keluarga berencana.]
  250. Knowledge, attitude and practice regarding use of obstetric services and family planning. [Pengetahuan, sikap, perilaku masyarakat pedesaan terhadap pelayanan obstetri dan keluarga berencana.]
  251. Knowledge, attitudes, and practice with respect to contraception of the black population in the rural area of West-Capeland. [Kennis en Gebruik van en Houding med Betrekking tot Kontrasepsie by Kleurlingman in die landelige Gebied van Wes-Kaapland.]
  252. Korea profile: family planning policies and programs.
  253. Korean family planning: past, present, and future.
  254. The labs' search for safer birth control.
  255. Lactation and contraception. [Lactancia y anticonception.]
  256. Lactation, fertility and the working woman: working conference organized by International Planned Parenthood Federation and the International Union of Nutritional Sciences.
  257. Lactational amenorrhea and natural family planning.
  258. Lactational amenorrhoea, prolactin and contraception. [Editorial]
  259. Law and planned parenthood.
  260. Law and planned parenthood.
  261. Law, policy and the use of non-physicians in family planning service delivery.
  262. Learning about population problem: children's attitudes toward family planning in India.
  263. Learning about the population problem: children's attitudes toward family planning in India.
  264. Legal innovations and family planning: how to handle barriers and break bottlenecks.
  265. Legitimating change: the expanded role of the Filipino professional paramedical in the delivery of family planning services.
  266. The level of cholesterol in oral contraceptive users: a six month survey at Dr. Soetomo Hospital, Surabaya (preliminary report) [Kadar asam lemak darah pada pemakai kontrasepsi oral selama enam bulan di rumah sakit Dr Soetomo Surabaya.]
  267. The life of the couple -- family planning, marriage counselling.
  268. Linking voluntary sterilization, family planning and health services.
  269. Little problems of contraception: mastodynia and oral contraceptives. [Ptits problemes de la contraception: mastodynies et contraceptifs oraux.]
  270. Little problems of contraception: metrorrhagia and oral contraception. [Petits problemes de la contraception: metrorragies et contraceptifs oraux.]
  271. Little problems of contraception: nausea due to oral contraceptives. [Petits problemes de la contraception: nausees dues aux contraceptifs oraux.]
  272. Liver biopsy findings after intake of oral contraceptives (author's transl) [Leberbiopsiebefunde nach Einnahme oraler Kontrazeptiva.]
  273. Liver function studies under the influence of hormonal contraceptives (Sequential preparations) [Leberfunktionsuntersuchungen unter dem Einfluss hormonaler Kontrazeptiva (Sequenzpraeparate)]
  274. Liver tumors and the contraceptive pill: controversies in aetiology, diagnosis and management.
  275. Liver tumours and oral contraceptives: a review of recent literature.
  276. Locus of control and contraceptive knowledge, attitudes and practice.
  277. Locus-of-control, perceived susceptibility to pregnancy and choice of contraceptive among college students.
  278. Logistics and supply management of contraceptives and other commodities in Ghana Ministry of Health.
  279. Long acting contraceptive steroids and interception.
  280. Long acting systemic steroids in contraceptive practice.
  281. Long-acting intrauterine contraceptive devices.
  282. Longitudinal predictive research: An approach to methodological problems in studying contraception.
  283. A look at community-based family planning in Japan.
  284. Low dose gestagens as oral contraceptives. [Les microprogestatifs en contraception orale.]
  285. Low-dose oral contraceptives: Asian Regional Workshop Report. (Letter from PIACT)
  286. Low-level, progesterone-releasing vaginal contraceptive devices.
  287. Majority of Americans approve of but don't plan to use sterilization as birth control.
  288. Malaysia: pattern of contraceptive preference.
  289. The Malaysian National Family Planning Programme: some facts and figures.
  290. Male contraception and family planning: a social and historical review.
  291. Male contraception. [La contraception masculine.]
  292. A male oral contraceptive from China: Gossypol. [Eine Pille fuer den Mann aus China: Gossypol.]
  293. Male responsibility in sexual activity and family planning: perspectives of a college mental health professional.
  294. Malnutrition, fertility, and family planning.
  295. Manual - Integrated Family Planning and Parasite Control Project in Malaysia.
  296. Manual for the midwife who works with family planning. [Manual para la partera que trabaja con planificacion familiar.]
  297. Manual of family planning for trained traditional birth attendants. [Manual de planificacion familiar para el partero empirico capacitado.]
  298. The many roles of market research in subsidized commercial contraceptive sales programs.
  299. Mao Zedong on the necessity of birth control.
  300. Market research and family planning.
  301. Massive drive to reenergize the family planning programme.
  302. Maternal and child health/family planning program implementation in the Central Province, Kenya.
  303. Maternal child health--family planning survey, Piaui State, Brazil- 1979 [tables]
  304. The Matlab Contraceptive Distribution Project.
  305. Maya Women and birth control: recommendations and conclusions. Final report. [La mujer Maya y el control de la natalidade: recomendaciones y conclusiones.]
  306. Mean cell volume in a working population: the effects of age, smoking, alcohol and oral contraception.
  307. Measurement of the Impact of Family Planning, Suva, 2 July-20 July 1979.
  308. Measuring a couple's fertility before prescription of a contraceptive method? [Bilan de fertilite du couple avant la prescriptiom d'une methode contraceptive?]
  309. Measuring the impact of a family planning program on fertility rates: some results for Thailand.
  310. Measuring the Thai family planning program's impact on fertility rates: a comparison of computer models.
  311. Medical and psychiatric aspects of contraception. [Aspects medico-psychiatriques de la contraception moderne.]
  312. Medical science and the current methods of family planning.
  313. Medroxyprogesterone acetate in depot form for contraception (author's transl) [Medroksyprogesteronacetat i depotform til kontraception.]
  314. Megaloblastic anemia due to folic acid deficiency after oral contraceptives.
  315. Menorrhagia, diffuse myometrial hypertrophy and the intrauterine contraceptive device: a report of fourteen cases.
  316. The metabolic effects of contraception with oestrogen-progestogen products (author's transl) [Effets metaboliques de la contraception oestroprogestative.]
  317. Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of Estrogen.
  318. Metabolic effects of oral contraceptives: influence of the dosage and nature of the substance used. [Effets metaboliques des contraceptifs oraux: influence de la dose et de la nature des molecules utilisees.]
  319. The methodology of measuring the impact of family planning programmes on fertility: manual 9.
  320. Mexico 1979: Contraceptive Prevalence Survey. Summary report.
  321. Migraine or headache and oral contraceptives. [Migaine ou cephalee et contraceptifs oraux.]
  322. Minor problems of contraception: absence of menstrual bleeding. [Petits problemes de la contraception: absence d'hemorragie de privation.]
  323. Mobile health units for family planning. [Policlinica movil de planificacion familiar.]
  324. Mobilization of rural communities for family planning.

     

  325. A model of births for developing countries and its use in the study of the demographic effect of birth control. (Doctoral dissertation, Carnegie-Mellon University, 1978)
  326. Model project for integrated nutrition, family planning and health care--Thailand.
  327. Modern contraception. [Moderne antikonzeption.]
  328. Modern contraception. [Suvremenna Kontratseptsiia.]
  329. Modifications in hemostasis and blood vessel walls during oral contraception (author's transl) [Modifications de l'hemostase et des parois vasculaires au cours de la contraception orale.]
  330. Morphological and clinical liver changes after taking oral contraceptives. [Morphologische und klinische Leberbefunde nach Einnahme oraler Kontrazeptiva.]
  331. Mortality among oral contraceptive users: Royal College of General Practitioners Oral Contraception Study.
  332. Mothers of large families and birth control education.
  333. Motivation towards contraceptive practice in Sri Lanka.
  334. Motivational strategy in family planning.
  335. Motivational strategy in family planning.
  336. Moves to reform contraceptive law in Francophone Africa.
  337. Multi-purpose survey of blacks - 1977: fertility and family planning. [Meerdoelige opname onder kleurlinge - 1977: fertiliteit en gesinsbeplanning.]
  338. The multiload copper intra-uterine contraceptive device in a mixed urban and rural population: a 3-year clinical evaluation.
  339. Multiload intra-uterine contraceptive device (MLCu250)
  340. Multiple births in former oral contraceptive users.
  341. Multipurpose survey among Blacks in urban areas - 1978: some practices with a contraceptive effect: abstinence and breast-feeding.
  342. Multipurpose survey of the white population, 1978: the possible influence of the national family planning program on white fertility. [Meerdoelige opname onder Blankes, 1978: die moontlike invloed van die nasionale gesinsbeplanningsprogram op Blanke fertiliteit.]
  343. Naproxen sodium in uterine pain following intrauterine contraceptive device insertion.
  344. Nasal spray contraceptives.
  345. National Contraceptive Prevalence Survey, Colombia 1978: general findings. [Encuesta Nacional de Prevalencia del Uso de Anticoncepcion Colombia 1978: resultados generales.]
  346. National Family Planning Program, Second Evaluation Conference, Health and Social Security Sector. [Programa Nacional de Planificacion Familiar, Segunda Reunion de Evaluacion, Sector Salud y Seguridad Social.]
  347. The national Office of Family Planning and Population: organization and goals. [L'Office National du Planning Familial et de la Population: organisaton et mission.]
  348. National Prevalence Survey on the use of contraceptive methods. Mexico. Report on results. July-October 1978. [Encuesta Nacional de Prevalencia en el uso de metodos anticonceptivos. Mexico. Informe de resultados. Julio a Octubre 1978.]
  349. National Survey on the Prevalence of Use of Contraceptive Methods. In 2 vols. [Encuesta Nacional de Prevalencia en el Uso de Metodos Anticonceptivos.]
  350. Natural family planning as an appropriate health technology: towards an agenda for global research and development.
  351. Natural family planning in Ireland.
  352. Natural family planning in Ireland.
  353. Natural family planning methods.
  354. Natural Family Planning Needs Assessment Questionnaire for Santa Clara County women of child-bearing years.
  355. Natural family planning.
  356. Natural family planning.
  357. Natural family planning: 'rhythm' redefined.
  358. Natural family planning: the contribution of fertility awareness to body-person integration.
  359. Natural methods of family planning. [Los metodos naturales de planificacion familiar.]
  360. Natural oestrogens for oral contraception.
  361. The need for rural family planning programmes in less developed countries.
  362. Nepal family planning and maternal child health project.
  363. Neurological complications of oral contraceptives (author's transl) [Accidents neurologiques dus aux contraceptifs oraux.]
  364. New acceptors of clinic, CBD, and sterilization services provided by family planning associations. [Tables]
  365. A new approach to family planning acceptance.
  366. New approaches to immunological contraception.
  367. The new birth control program.
  368. A new cause of ectopic pregnancy: intrauterine contraceptives. [Una nuova causa di gravidanza ectopica: i dispositivi intrauterini.]
  369. New contraceptive cap custom-made for cervix.
  370. New directions in community based family planning in Brazil.
  371. New issues, new options: a management perspective on population and family planning.
  372. New long-acting injectable microcapsule contraceptive system.
  373. A new method of contraception: TA-RO-CAP, the soluble cervical cap. [une nouvelle methode de contraception: TA-RO-CAP, cap-soluble.]
  374. A new set of projections of population size and vital rates for India up to 2001 (With explicit accounting of changes in family planning and nuptiality patterns)
  375. Newer developments in steroidal contraceptives: injectables, subcutaneous implants, intravaginal rings.
  376. Newer intrauterine contraceptives may be choice for women apprehensive about pill, research says.
  377. No coercion in birth control.
  378. Norethisterone oenanthate as an injectable contraceptive.
  379. Norethisterone-oenanthate (Norigest) as a contraceptive for the immediate postpartum cases. [Norethisterone-oenanthat (Norigest) sebagai kontrasepsi depot pasca persalinan segera.]
  380. Notes on population and family planning in Vietnam.
  381. Notes on the main complications and contraindications associated with the use of oral contraceptives. [Considerazioni sulle principali complicanze e controindicazioni dell'uso dei contracettivi orali.]
  382. Nutrition counseling at planned parenthood centers.
  383. Nutrition during pregnancy, lactation, and oral contraception.
  384. Observation of family planning accomplishment in West Kalimantan.
  385. Obstacles to contraception.
  386. Obstetric service in the villages and its relationship with the family planning program. [Pelayanan kebidanan di pedesaan dalam kaitannya dengan program keluarga berencana.]
  387. Obstruction of the axillary artery: cervical rib or a complication of oral contraceptives in the young woman? [Obliteration de l'artere axillaire: cote cervicale ou accident des contraceptifs oraux chez la femme jeune?]
  388. Office visits for family planning, National Ambulatory Medical Care Survey: United States, 1977.
  389. On Integration in family planning programming.
  390. Open forum. How do you manage the teenage patient who comes to you for contraception?
  391. Opening remarks: the role of contraception and family planning in Kenya.
  392. Ophthalmological involvement during contraceptive therapy. [Alterazioni oculari nel corso di terapia contraccettiva.]
  393. Opinions of post-natal mothers on family planning.
  394. Optimal time for contraceptives after the termination of pregnancy. [Saat optimal dimulainya kontrasepsi sesudah suatu pengakhiran kehamilan.]
  395. An optimization model for the allocation of resources in family planning programs.
  396. Optimum dosage of an oral contraceptive: a report from the study of seven combinations of norgestimate and ethinyl estradiol.
  397. Oral contraception and coronary disease. [Contraceptifs oraux et pathologie vasculaire.]
  398. Oral contraception and depression.
  399. Oral contraception and multiple sclerosis (author's transl) [Contraccezione orale e sclerosi multipla.]
  400. Oral contraception and neoplasia.
  401. Oral contraception in a regional centre: variations in age profile and profession, from 21,000 case notes in 5 years (1973-1977) [Contraception oral dans la Region centre: variation de profil d'age et de profession apropos de 21000 dossiers en 5 ans (1973-1977)]
  402. Oral contraception reviewed.
  403. Oral contraception with an associated therapeutic action using a progestational method at two levels (author's transl) [Contraceptoin orale a effet therapeutique associe par une methode progestative a 2 paliers.]
  404. Oral contraception.
  405. Oral contraception.
  406. Oral contraceptive administration and hepatocellular neoplasms in the rat: preliminary results [abstract]
  407. Oral contraceptive and antiepileptic drug interaction resulting in contraceptive failure.
  408. Oral contraceptive hypertension in black women. (Abstract only)
  409. Oral contraceptive pills and endometrial cancer. [Letter]
  410. Oral contraceptive risks: a realistic appraisal.
  411. Oral contraceptive use and fasting triglyceride plasma cholesterol and HDL cholesterol.
  412. Oral contraceptive use and secondary amenorrhea.
  413. Oral contraceptive use and vitamin nutrition status of malnourished women--effects of continuous and intermittent vitamin supplements.
  414. Oral contraceptive-induced chorea: clinical and experimental observations. (Abstract only))
  415. Oral contraceptive-induced ischemic bowel disease.
  416. Oral contraceptives and birth defects. (Letter)
  417. Oral contraceptives and breast cancer risk.
  418. Oral contraceptives and breast cancer: preliminary results of a French survey. [Contraceptifs oraux et cancer du sein: resultats preliminaires d'une enquete francaise.]
  419. Oral contraceptives and cigarette smoking: the effect on blood pressure in Hong Kong Chinese.
  420. Oral contraceptives and cutaneous microcirculation (author's transl) [Contraceptifs oraux et microcirculation cutanee.]
  421. Oral contraceptives and depression.
  422. Oral contraceptives and depression: prophylactic and therapeutic effects of pyridoxine supplementation.
  423. Oral contraceptives and depressive symptomatology: biologic mechanisms.
  424. Oral contraceptives and endometrial cancer.
  425. Oral contraceptives and endometriosis.
  426. Oral contraceptives and fatal subarachnoid haemorrhage.
  427. Oral contraceptives and glucidolipid metabolism (author's transl) [Contraceptifs oraux et metabolisme glucido-lipidique.]
  428. Oral contraceptives and HDL cholesterol (Editorial) [P-piller och HDL-kolesterol.]
  429. Oral contraceptives and hypertension.
  430. Oral contraceptives and liver tumors.
  431. Oral contraceptives and neoplasia.
  432. Oral contraceptives and plasma protein metabolism.
  433. Oral contraceptives and platelets. [Anticonceptivos orales y plaquetas.]
  434. Oral contraceptives and serum enzymes in women.
  435. Oral contraceptives and the liver. [Orale anticonceptiva en de lever.]
  436. Oral contraceptives and the periodontium. [Orale Kontrazeptiva und Parodontium.]
  437. Oral contraceptives and the risk of cancer (author's transl) [P-piller och cancerrisk.]
  438. Oral contraceptives and trisomy 21: a retrospective study of 730 cases (author's transl) [Contraceptifs oraux et trisomy 21: etude retrospective de sept cent trente cas.]
  439. Oral contraceptives and vascular disorders: value of epidemiological studies (author's transl) [Contraceptifs oraux et pathologie vasculaire: apports de l'epidemiologie.]
  440. Oral contraceptives in otosclerosis? (Letter) [Orale Kontrazeptiva bei Otosklerose?]
  441. Oral contraceptives.
  442. Oral contraceptives: a guide for programs and clinics. 3red ed.
  443. Oral contraceptives: a guide for programs and clinics. 3rd ed.
  444. Oral contraceptives: a new suspicion. [Contraceptifs oraux: une nouvelle mefiance.]
  445. Oral contraceptives: an update.
  446. Oral contraceptives: cardiovascular complications and additional risk factors (author's transl) [Ovulationshemmer: kardiovaskulaere Komplikationen und zusaetzliche Risikofaktoren.]
  447. Oral contraceptives: low dose versus high dose estrogen.
  448. Oral estro-progestative contraception and cervical and vaginal cytology. [La contraception orale par oestro-progestatifs et la cytologie cervico-vaginale.]
  449. Oral oestro-progestative contraception and cervical and vaginal cytology (author's transl) [La contraception orale par oestro-progestatifs et la cytologie cervico-vaginale.]
  450. Oral-contraceptive use in relation to myocardial infarction.
  451. Organisation development at the district level family planning programme: a case of Andhra Pradesh.
  452. Organized family planning services in the United States, 1976-1977.
  453. Orientations of New Jersey school nurses toward adolescent sexual behavior and contraceptive needs.
  454. Outcome of pregnancy and attitude toward family planning among women in a rural area.
  455. The outcome of pregnancy in former contraceptive users: national surveys INSERM 1972-1976. [Contraception et grossesse ulerieure: enquetes nationales INSERM 1972-1976.]
  456. Outcome of pregnancy in women using different methods of contraception.
  457. Overdose of oral contraceptive causing neurologic complications. [Oralis fogamzasgatlo tuladagolas okozta idegrendszeri szovodmeny.]
  458. An overview of experience with vaginal contraceptives in the United States.
  459. An overview of family planning in Korea, 1961-1978.
  460. An overview of family planning in Korea.
  461. Ovulation inhibition with a combined oral contraceptive containing 20 micrograms ethinyl estradiol and 250 micrograms levonorgestrel: serum levels of the active ingredients and FSH, LH estradiol 17-beta and progesterone.
  462. Ovulation recovery after hormonal contraception.
  463. Paediatric aspects of family planning.
  464. Paradoxical embolism associated with oral contraceptives: an underdiagnosed lesion?
  465. Parasitism and contraceptives: a preliminary survey of the effect on haemoglobin levels.
  466. Parental choice and family planning: the acceptability, use, and sequelae of four methods.
  467. Parents and teens agree: teenagers should get birth control information from parents primarily.
  468. Past and current contraceptive use in Pakistan.
  469. Pathogenicity of vascular accidents during oral contraceptive therapy (author's transl) [Pathogenie des accidents vasculaires observes pendant la prise de contraceptifs oraux.]
  470. Pathologic effects of oral contraceptives.
  471. Patients treated for gynecologic cancer after use of oral contraceptives and IUD. [(OFG) es eszkozok (IUD) haznalata utan kezelt nogyogyaszati carcinomas betegeink.]
  472. The pattern of supply, distribution, and use of oral contraceptive pill in rural areas in Uttar Pradesh.
  473. Patterns of aggregate and individual changes in contraceptive practice, United States, 1965-1975.
  474. Patterns of aggregate and individual changes in contraceptive practices, United States, 1965-1975.
  475. Pelvic actinomycosis and intrauterine contraceptive devices. (Letter)
  476. Pelvic actinomycosis in association with an intrauterine contraceptive device.
  477. Pelvic actinomycosis in women using intrauterine contraceptive devices.
  478. Pelvic colonization with Actinomyces in women using intrauterine contraceptive devices.
  479. People's perception of family planning incentives and disincentives: findings from a survey of a sample population in Karnataka State.
  480. Peptide agents may spark contraception revolution.
  481. Peptide contraception: antifertility properties of LH-RH analogues.
  482. Permanent fertility regulation program in the General Office of Maternal-Child Health and Family Planning of Mexico's Secretary of Health and Welfare. [Programa de limitacion permanente de la fecundidad en la direccion general de Salud Materno Infantil y Planificacion Familiar de la Secretaria de Salubridad y Asistencia de Mexico.]
  483. Perspectives in male contraception. [Perspectives de la contraception masculine.]
  484. Perspectives in oral contraception (author's transl) [Contraception orale: perspectives.]
  485. Petition for promulgation of a trade regulation rule (TRR) dealing only with advertising of over-the-counter vaginal contraceptives.
  486. Petition for promulgation of a trade regulation rule (TRR) dealing only with advertising of over-the-counter vaginal contraceptives.
  487. Pharmaceutical control and contraception. [Pharmacovigilance et contraception.]
  488. The pharmaceutical industry and development of new contraceptives.
  489. Philippines: mobilizing communities in delivering family planning services.
  490. Philosophical background for humanistic family planning.
  491. Physiological and psychological effects of vitamin E and B6 on women taking oral contraceptives.
  492. Physiostat: normophasic oral contraceptive. [Le Physiostat: contraceptif oral normophasique.]
  493. Pituitary and ovarian function in women receiving hormonal contraception.
  494. Pituitary prolactinoma and estrogen contraceptives. (Editorial)
  495. The place of sterilization as a component of a comprehensive family planning.
  496. The place of the normophasic estroprogestative preparation Physiostat in oral contraception. [Place du physiostat estroprogestatif normophasique en contraception orale.]
  497. Planned parenthood adulterates NFP.
  498. Planned Parenthood and Women's Development Programme: interim report.
  499. Planned parenthood: its role in national development.
  500. Planning and development of educational communication activities for health and family planning programs: Haiti, 1979. Report on the Fourth Follow-up Seminar, Cap-Haitien, Haiti, April 25-May 4, 1979.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.